This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, University of California. Active years: 2011.
Company Filing History:
1 out of 3,737 
1 out of 16,008 
Years Active: 2011
Title: Judy Dering: Innovator in Cancer Research
Introduction
Judy Dering is a prominent inventor based in Westlake Village, CA (US). She has made significant contributions to the field of cancer research, particularly in the development of predictive markers for breast cancer treatment. Her work has the potential to improve patient outcomes through more personalized approaches to therapy.
Latest Patents
Judy Dering holds a patent for her invention titled "Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers." This invention relates to methods and compositions that are useful in the diagnosis, treatment, and management of cancers that express specific genes, including moesin, caveolin 1, and yes-associated protein 1. Her innovative approach aims to enhance the understanding of how these markers can influence treatment responses.
Career Highlights
Throughout her career, Judy has worked with notable organizations, including Bristol-Myers Squibb Company and the University of California. Her experience in these esteemed institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Judy Dering has collaborated with distinguished colleagues such as Richard S. Finn and Dennis J. Slamon. These partnerships have further enriched her research and expanded the impact of her work in cancer diagnostics and treatment.
Conclusion
Judy Dering's contributions to cancer research through her innovative patents and collaborations highlight her role as a key figure in the scientific community. Her work continues to pave the way for advancements in cancer treatment and patient care.